Psychedelic Drug Market Could Reach $14.9 Billion by 2035, Report Says
The forecast reflects a shift in mental health, where ketamine, psilocybin, MDMA, and other compounds are moving from fringe to mainstream.
Read More
Trump Signs Executive Order to Accelerate FDA Review of Psychedelic Therapies
Trump framed the order as a response to the mental health crisis facing American veterans. Psychedelic therapy advocates are watching the move closely.
Read More
How Psychedelics May Rewire the Brain, According to a Major New Scan Analysis
Researchers combined more than 500 scans and found that psychedelics all pushed the brain toward a similar pattern of activity.
Read More
MDMA Side Effects: What Clinical Trials and Research is Showing Us
The FDA is close to approving MDMA to treat PTSD. So what are some of the most common side effects from MDMA-assisted psychotherapy?
Read More
Monash University Just Published the World’s First Clinical Guideline for MDMA-Assisted Psychotherapy
Monash University has delivered what no institution has before: a formal clinical practice guideline for MDMA assisted psychotherapy.
Read More
Bipartisan Bill Would Let Doctors Administer MDMA and Psilocybin to Seriously Ill Patients
The Freedom to Heal Act would allow doctors to legally administer Schedule I drugs like MDMA and psilocybin to very ill patients.
Read More
This is Why MAPS’ MDMA PTSD Clinical Trial was Denied
The August 2024 letter reveals three critical flaws that doomed the groundbreaking psychedelic therapy trial.
Read More
Lorde Says MDMA Therapy Helped Cure Her Stage Fright
Lorde revealed that guided MDMA-assisted therapy helped her address deep-rooted stage fright that had been quietly shadowing her career.
Read More
MDMA’s Potential Role in Trauma Protection: A New Study on Nova Festival Survivors
In a groundbreaking study, MDMA may have provided psychological protection to survivors of the Nova music festival.
Read More
University of Texas Gets $4.9M Grant to Study MDMA as PTSD Treatment
The Department of Defense just gave the University of Texas a $4.9M grant to study MDMA to treat PTSD in veterans groups.
Read More